In December 2015, the president of the Philippines, Benigno Aquino III, along with others, made an agreement with the pharmaceutical company Sanofi to buy three million doses of Dengvaxia, the very first vaccine approved for dengue. The idea was to provide a million schoolchildren, who were nine years old, with three doses of the vaccine … Continue reading Faltering Hope: Examining the Flaws of the Dengue Vaccine and its Impact on Public Health